Development of One-Step Real-Time PCR Assay for Titrating Trivalent Live Attenuated Influenza Vaccines
Yang Zang,Dongchuan Du,Peng Ge,Yongqing Xu,Xintao Liu,Yan Zhang,Weiheng Su,Irina Kiseleva,Larisa Rudenko,Fei Xu,Wei Kong,Chunlai Jiang
DOI: https://doi.org/10.4161/hv.34453
2014-01-01
Human Vaccines & Immunotherapeutics
Abstract:Traditionally, infectivity of a trivalent live attenuated influenza vaccines (LAIVs) is titrated by determining the 50% egg infectious dose assay (EID50) or plaque forming units (PFU), which requires specific monoclonal antibodies to neutralize 2 strains while estimating the titer of the non-neutralized strain. Compared to this time-consuming, laborious, subjective and variable process, reverse transcription-quantitative real-time PCR (RT-qPCR) technology has advantages of rapidity, sensitivity, reproducibility and reduced contamination, thus has been applied widely for detecting pathogens and measuring viral titers. In this study, the critical harvest time was determined to be 18 h post-infection (hpi) for type A influenza and 12 hpi for type B influenza, but no significant difference between titers at 12 hpi and 18 hpi for the type B strain was observed. In conclusion, trivalent LAIVs can be titrated simultaneously within 24 h by this one-step RT-qPCR assay, which yielded titers comparable to those obtained by the traditional EID50 assay. Therefore, the RT-qPCR assay may be used as a highly specific, sensitive, precise and rapid alternative to the EID50 assay for titering LAIVs.